Biotech and other emerging technology is jeopardizing the future of the human race.
In its latest effort, Fidelity Investments is aiming to drive billions of dollars of global finance capital into the emerging field of “synthetic biology”, using promotions and social media (as in its “Follow the Green Line” ad campaign) to raise interest. Fidelity is also trying to take on water shortage issues, “personalized medicine” and has partnered with the TED Talks (along with dozens of other firms) that have become a self-proclaimed authority on where technology is going. For Fidelity, it is part of an effort to bolster the firm’s image as responsible and innovative. But is it?
Just as big money has backedcarbon credit schemes and green technology, Fidelity is making a push to back ‘synthetic biology,’ which it says could be the “defining technology of the 21st Century,” though admittedly it is still in the ‘experimental phase’. In essence, synthetic biology is just another buzz term for what has already become the very controversial and dangerous field of biotech & genetic engineering.
Join us on our
Share this page with your friends
on your favorite social network: